Basit öğe kaydını göster

dc.contributor.authorde Ruiter, PE
dc.contributor.authorKayserili, H
dc.contributor.authorRodrigues, C
dc.contributor.authorBode, HH
dc.contributor.authorDelemarre-van de Waal, HA
dc.contributor.authorDrop, SLS
dc.contributor.authorBoehmer, ALM
dc.contributor.authorBrinkmann, AO
dc.contributor.authorSandkuijl, LA
dc.contributor.authorHalley, DJJ
dc.contributor.authorNiermeijer, MF
dc.contributor.authorAndersson, S
dc.contributor.authorde Jong, FH
dc.contributor.authorde Vroede, MA
dc.contributor.authorOtten, BJ
dc.contributor.authorRouwe, CW
dc.contributor.authorMendonca, BB
dc.date.accessioned2021-03-05T21:32:56Z
dc.date.available2021-03-05T21:32:56Z
dc.date.issued1999
dc.identifier.citationBoehmer A., Brinkmann A., Sandkuijl L., Halley D., Niermeijer M., Andersson S., de Jong F., Kayserili H., de Vroede M., Otten B., et al., "17 beta-hydroxysteroid dehydrogenase-3 deficiency: Diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.84, ss.4713-4721, 1999
dc.identifier.issn0021-972X
dc.identifier.othervv_1032021
dc.identifier.otherav_d968a8cd-3799-4cb0-9e94-a4a27ae05cef
dc.identifier.urihttp://hdl.handle.net/20.500.12627/143404
dc.identifier.urihttps://doi.org/10.1210/jc.84.12.4713
dc.description.abstract17 beta-Hydroxysteroid dehydrogenase-3 (17 beta HSD3) deficiency is an autosomal recessive form of male pseudohermaphroditism caused by mutations in the HSD17B3 gene. In a nationwide study on male pseudohermaphroditism among all pediatric endocrinologists and clinical geneticists in The Netherlands, 18 17 beta HSD3-deficient index cases were identified, 12 of whom initially had received the tentative diagnosis androgen insensitivity syndrome (AIS). The phenotypes and genotypes of these patients were studied. Endocrine diagnostic methods were evaluated in comparison to mutation analysis of the HSD17B3 gene. RT-PCR studies were performed on testicular ribonucleic acid of patients homozygous for two different splice site mutations. The minimal incidence of 17 beta HSD3 deficiency in The Netherlands and the corresponding carrier frequency were calculated. Haplotype analysis of the chromosomal region of the HSD17B3 gene in Europeans, North Americans, Latin Americans, Australians, and Arabs was used to establish whether recurrent identical mutations were ancient or had repeatedly occurred de novo.
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.title17 beta-hydroxysteroid dehydrogenase-3 deficiency: Diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
dc.contributor.department, ,
dc.identifier.volume84
dc.identifier.issue12
dc.identifier.startpage4713
dc.identifier.endpage4721
dc.contributor.firstauthorID124423


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster